ALPL and hypophosphatasia: Instead, our structural analyses identified some ligands of the M4 site to be critical structural elements of TNAP which, despite their distant location from the active site have a dominant role on the active site integrity when mutated to residues such as encountered in some hypophosphatasia patients (http://www.esep.uvsq.fr/03_hypo_mutations.php).